Intravitreal Bevacizumab

DRUG18 trials

Sponsors

Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Gunma University Hospital Department of Ophthalmology, Asan Medical Center, Asociación para Evitar la Ceguera en México, National Taiwan University Hospital

Conditions

Active Photocoagulated Diabetic RetinopathyAge Related Macular DegenerationAngioid StreaksChoroidal NeovascularizationDiabetes Mellitus Type 2Diabetic Macular EdemaDiabetic Proliferative RetinopathyDiabetic Retinopathy

Phase 2

Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment

TerminatedNCT00417833

Asociación para Evitar la Ceguera en MéxicoChoroidal Neovascularization, Diabetic Proliferative Retinopathy, Vascular Vein Oclussion

Start: 2005-12-31End: 2006-07-31Updated: 2024-06-03

Intravitreal Bevacizumab for Diabetic Retinopathy

TerminatedNCT00600262

Asociación para Evitar la Ceguera en MéxicoActive Photocoagulated Diabetic Retinopathy, Proliferative Diabetic Retinopathy, Severe Nonproliferative

Start: 2005-12-31End: 2006-06-30Updated: 2024-05-30

Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema

CompletedNCT01571232

Retina Macula InstituteDiabetic Macular Edema, Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy

Start: 2012-04-30End: 2015-03-31Updated: 2021-03-30

Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema

CompletedNCT02663141

Tehran University of Medical SciencesDiabetic Macular Edema

Start: 2015-06-30End: 2016-06-30Updated: 2016-07-06

Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical Trial

Shahid Beheshti University of Medical SciencesAge Related Macular Degeneration

Start: 2018-09-30End: 2019-02-28Target: 40Updated: 2018-08-01

Phase 3

Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema

WithdrawnNCT00417716

Asociación para Evitar la Ceguera en MéxicoDiabetes Mellitus Type 2, Diabetic Macular Edema

Start: 2005-09-30End: 2006-05-31Updated: 2024-06-03

Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks

TerminatedNCT00599820

Asociación para Evitar la Ceguera en MéxicoAngioid Streaks, Choroidal Neovascularization

Start: 2005-11-30End: 2006-05-31Updated: 2024-06-03

Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA)

CompletedNCT00997191

University of Sao PauloDiabetic Macular Edema

Start: 2009-10-31End: 2011-11-30Updated: 2013-03-04

Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy

CompletedNCT01976923

J. Fernando Arevalo, MD FACSTractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy

Start: 2013-11-30End: 2018-10-31Updated: 2018-10-09

A Dosing Study of Intravitreal Bevacizumab for Retinopathy of Prematurity

CompletedNCT05712642

Cairo UniversityRetinopathy of Prematurity

Start: 2020-02-01End: 2021-01-28Updated: 2023-02-03

Phase 4

Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema

TerminatedNCT04991350

Cairo UniversityDiabetic Macular Edema, Diabetic Retinopathy, Macular Ischemia +1

Start: 2021-11-26End: 2022-11-01Updated: 2023-02-16

Unknown Phase

Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy

Asan Medical CenterPolypoidal Choroidal Vasculopathy

Start: 2006-05-31End: 2008-05-31Target: 20Updated: 2006-10-04

Intravitreal Injection of Bevacizumab and Gas for Diabetic Premacular Hemorrhage With Active Fibrovascular Proliferation

National Taiwan University HospitalDiabetic Retinopathy With Premacular Hemorrhage

Start: 2007-01-31End: 2008-12-31Updated: 2008-05-07

Major and Macular Branched Retinal Venous Occlusion

CompletedNCT01219205

Hallym University Medical CenterMacular Edema

Start: 2008-03-31End: 2010-08-31Updated: 2010-10-13

Effect of Intravitreal Anti-VEGF on Retinal Vessels Diameter

University of MalayaAge Related Macular Degeneration

Start: 2012-04-30Target: 30Updated: 2012-06-22

Efficacy and Safety of Intravitreal Bevacizumab for Threshold ROP.

Sivakami A PaiStage 2+ or Stage 3+ Retinopathy of Prematurity in Zone I or Zone II.

Start: 2010-01-31End: 2012-12-31Target: 50Updated: 2012-10-16

Clinical study to examine the efficacy of the intravitreal injection of anti-VEGF antibody (Avastin) for intraocular neovascular disease and macular edema

Active, not recruitingJPRN-UMIN000014338

Department of Ophthalmology and Visual Science, Chiba University Graduate School of MedicineOphthalmic neovascular disease Diabetic retinopathy Retinal vein occlusion

Start: 2006-06-21Target: 3000Updated: 2026-06-29

The clinical trial to examine the efficacy of the intravitreal injection of anti-VEGF antibody Bevacizumab(Avastin) for severe retinopathy of prematurity.

RecruitingJPRN-UMIN000018069

Gunma University Hospital Department of OphthalmologyRetinopathy of prematurity

Start: 2013-07-01Target: 4Updated: 2026-06-29